Infliximab trough concentrations during maintenance therapy are associated with endoscopic and histologic healing in ulcerative colitis
Papamichael, K., Rakowsky, S., Rivera, C., Cheifetz, A. S., Osterman, M. T.
Published in Alimentary pharmacology & therapeutics (01.02.2018)
Published in Alimentary pharmacology & therapeutics (01.02.2018)
Get full text
Journal Article
Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
Forde, K. A., Haynes, K., Troxel, A. B., Trooskin, S., Osterman, M. T., Kimmel, S. E., Lewis, J. D., Re III, V. Lo
Published in Journal of viral hepatitis (01.04.2012)
Published in Journal of viral hepatitis (01.04.2012)
Get full text
Journal Article
P637 Ozanimod efficacy with or without concomitant corticosteroids in 5-ASA–exposed, advanced therapy–naive, immunomodulator-naive patients with ulcerative colitis: a post hoc analysis of True North
Horst, S, Fischer, M, Kinnucan, J A, Sauk, J S, Wu, H, Jain, A, Ahmad, H A, Osterman, M T, Rosen, M, Sands, B E
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
P567 Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North study
Battat, R, Panaccione, R, Hart, A, Hisamatsu, T, Ahmad, H A, Osterman, M T, Wu, H, Jain, A, Rosen, M, Siegmund, B
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
DOP43 Rapidity of ozanimod-induced symptomatic response and remission in patients with moderately to severely active Ulcerative Colitis: Results from the induction period of True North
Siegmund, B, Axelrad, J, Pondel, M, Osterman, M T, Ahmad, H A, Memaj, A, Regueiro, M, Armuzzi, A, Afzali, A
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
P609 Impact of prior biologic exposure on durability of recaptured response to ozanimod during the True North open-label extension study
Colombel, J F, Rubin, D T, Vermeire, S, Jain, A, Canavan, J B, Wu, H, Lawlor, G, Osterman, M T, Dignass, A, Regueiro, R
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P773 Extended induction in the True North open-label extension study: clinical outcomes of ~2 years of ozanimod treatment
Vermeire, S, Colombel, J F, Chiorean, M V, Ghosh, S, Jain, A, Lawlor, G, Osterman, M T, Wu, H, Canavan, J B, Rubin, D T
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
DOP43 Extended induction in the True North OLE study: ozanimod efficacy in biologic-naive and biologic-experienced patients
Dignass, A, Regueiro, M, Colombel, J F, Jain, A, Canavan, J B, Wu, H, Lawlor, G, Osterman, M T, Vermeire, S, Rubin, D T
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P715 Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
Vermeire, S, Colombel, J F, Rubin, D T, Ghosh, S, Jain, A, Lawlor, G, Osterman, M T, Wu, H, Canavan, J B, Chiorean, M V
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
DOP39 Endoscopic, histologic, and combined outcomes with reinitiation of ozanimod after temporary discontinuation: 2-year interim analysis of the True North open-label extension study
Vermeire, S, Dignass, A, Colombel, J F, Jain, A, Canavan, J B, Wu, H, Lawlor, G, Osterman, M T, Rubin, D T, Regueiro, M
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P687 Durability of recaptured response to ozanimod during the True North open-label extension
Dignass, A, Regueiro, M, Colombel, J F, Jain, A, Canavan, J B, Wu, H, Lawlor, G, Osterman, M T, Vermeire, S, Rubin, D T
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
P545 Long-term efficacy of ozanimod up to 3 years in patient response subgroups identified using group-based trajectory modelling
Schreiber, S W, Feagan, B G, Sands, B E, Rieder, F, Torres, J, Liu, Z, Jain, A, Poehler, A M, Wu, H, Osterman, M T, Abreu, M T, Dulai, P S
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
P789 Impact of risk factors for Janus kinase inhibitor use identified by the Pharmacovigilance Risk Assessment Committee on the safety and efficacy of ozanimod in patients with moderately to severely active ulcerative colitis
Siegmund, B, Kuehbacher, T, Armuzzi, A, Hart, A, Bressler, B, Feagan, B G, Wu, H, Ahmad, H A, Osterman, M T, Charles, L, Poehler, A M, Jain, A, Danese, S
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
DOP78 Efficacy of ozanimod by patient response trajectory subgroups identified using group-based trajectory modelling: a post hoc analysis of the phase 3 True North study
Schreiber, S W, Feagan, B G, Sands, B E, Rieder, F, Torres, J, Liu, Z, Jain, A, Poehler, A M, Wu, H, Osterman, M T, Abreu, M T, Dulai, P S
Published in Journal of Crohn's and colitis (24.01.2024)
Published in Journal of Crohn's and colitis (24.01.2024)
Get full text
Journal Article
P316 Ozanimod is an efficacious oral therapy after, 5-ASA failure in immunomodulator- and biologic-naive patients with ulcerative colitis: post hoc analysis from True North
Sands, B E, Dignass, A, Irving, P, Chiorean, M, Long, M, Eren, D, Ahmad, H A, Osterman, M T, Petersen, A, Elegbe, A, Ritter, T, Danese, S
Published in Journal of Crohn's and colitis (21.01.2022)
Published in Journal of Crohn's and colitis (21.01.2022)
Get full text
Journal Article
P752 Predictors of time to relapse upon ozanimod withdrawal in patients with moderately to severely active ulcerative colitis
Vermeire, S, Abraham, B, Bressler, B, Reinisch, W, Axelrad, J E, Jain, A, Memaj, A, Akukwe, L, Liu, W J, Osterman, M T, Canavan, J B, Sands, B E
Published in Journal of Crohn's and colitis (30.01.2023)
Published in Journal of Crohn's and colitis (30.01.2023)
Get full text
Journal Article
DOP45 Adequate infliximab exposure during the induction phase is associated with early complete fistula response in patients with fistulizing Crohn’s disease: a post-hoc analysis of the ACCENT-2 trial
Vande Casteele, N, Papamichael, K, Jeyarajah, J, Osterman, M T, Cheifetz, A S
Published in Journal of Crohn's and colitis (25.01.2019)
Published in Journal of Crohn's and colitis (25.01.2019)
Get full text
Journal Article
DOP59 Maintenance of remission with tofacitinib in patients with ulcerative colitis: Updated results of a subpopulation analysis from an open-label, long-term extension study, OCTAVE Open
Colombel, J F, Osterman, M T, Ibanez, P, Thorpe, A J, Zhang, H, Lawendy, N, Su, C, Reinisch, W
Published in Journal of Crohn's and colitis (15.01.2020)
Published in Journal of Crohn's and colitis (15.01.2020)
Get full text
Journal Article
P531 Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment
Reinisch, W, Osterman, M T, Doherty, G, Marren, A, Woodworth, D A, Lawendy, N, Kwok, K, Maller, E, Su, C
Published in Journal of Crohn's and colitis (25.01.2019)
Published in Journal of Crohn's and colitis (25.01.2019)
Get full text
Journal Article
P390 Methotrexate is not superior to placebo in maintaining remission in patients with ulcerative colitis: results from the MERIT-UC study
Herfarth, H, Barnes, E L, Jackson, S, Valentine, J F, Hanson, J, Higgins, P D R, Isaacs, K L, Osterman, M T, Sands, B E, Lewis, J D
Published in Journal of Crohn's and colitis (16.01.2018)
Published in Journal of Crohn's and colitis (16.01.2018)
Get full text
Journal Article